# clm_298FEDBEF107

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 287,379,000 United States dollar  
valid_from: 2014-03-31  
valid_to: 2014-06-30  
published: 2014-05-08  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_3B3C62D2F90C  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly research and development: 287,379,000 United States dollar", as of 2014-03-31 (until 2014-06-30). Claim clm_298FEDBEF107, https://asof.is/claim/clm_298FEDBEF107, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q1 FY2014, filed 2014-05-08  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217614000022/0001532176-14-000022-index.htm (primary, SEC EDGAR 10-Q Q1 FY2014, published 2014-05-08)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 224,045,000 United States dollar | valid 2013-09-30 to 2014-03-31 | conf 0.95 | superseded | superseded_by [clm_298FEDBEF107](/claim/clm_298FEDBEF107.md) | [clm_33823C33ED82](/claim/clm_33823C33ED82.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.